Work

P125 - Influence of disease duration on adalimumab efficacy in Crohn's disease: subanalysis of the CARE trial

Year: 2009

Type: conference-abstract

Abstract: W. Reinisch, R. Lofberg, E. Louis, M. Kron, A. Camez, A. Robinson, P.F. Pollack; P125 - Influence of disease duration on adalimumab efficacy in Crohn's dis

Source: Journal of Crohn s and Colitis

DOI: 10.1016/s1873-9946(09)60152-5

Authors: W. Reinisch, R. Lofberg, E. Louis, M. Kron, A. Camez, A. Robinson, P.F. Pollack

Institutions: Robert Bosch Hospital, Medical University of Vienna, Karolinska Institutet, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Liège, Abbott (Germany), Abbott (United States)

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2013446913

Cites:

Cited by: 2

Related to: 10